Lumida
/BCS
⌘K
Barclays PLC

Barclays PLC

BCS
$27.82USD-1.45%-0.41 today

MARKET CAP

52.6B

P/E (TTM)

56.0x

FWD P/E

48.1x

DAY RANGE

$27 – $28

52W RANGE

$18
$28

AI Summary

Stalk
StalkMedium

BCS remains in a Stage 2 advancing uptrend with active higher highs and higher lows continuation, yet price is extended above the rising 9/21 EMAs and overbought, indicating near-term momentum fatigue. The Value + EPS strategy favors deferred mean-reversion entries, so execution should be stalked for a pullback and acceptance into the EMA support zone.

  • Q1 2026 ROTE of 14% up from 11.3% last year.
  • Net interest income grew 12% YoY, targeting >£13.5 bn in FY26.
  • Recorded £228 m securitized products impairment, part of £823 m Q1 charges.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Barclays PLC (LON: BARC) is one of the leading multinational financial institutions based in the UK, providing a comprehensive range of financial services, including retail banking, investment banking, and wealth management. The company operates across multiple segments, aiming to leverage its diversified business model to achieve sustainable growth and operational efficiencies while navigating complex economic landscapes. Barclays has a notable presence in both the UK and US markets and continues to focus on enhancing its investment banking capabilities amid evolving regulatory environments and competitive pressures.

Bull says

  • Q1 2026 ROTE of 14% up from 11.3% last year.
  • Net interest income grew 12% YoY, targeting >£13.5 bn in FY26.
  • Announced £500 m buyback and ~7.4% dividend yield underscores shareholder returns.
  • Cost-to-income ratio improved to 56%, boosting operating leverage.
  • Analysts maintain Moderate Buy with $32.80 ADR price target.
  • High earnings yield and strong profitability factors support valuation.

Bear says

  • Recorded £228 m securitized products impairment, part of £823 m Q1 charges.
  • Rising impairments signal elevated credit risk from fraud in lending.
  • Liquidity pressures may hamper asset-to-cash conversion under stress.
  • Interest-rate sensitivity could compress net interest margin in rising-rate cycles.
  • Volatility in investment banking revenues may dampen fee income.
  • Regulatory and RWA pressures may constrain future capital allocation.

Investment themes with BCS

Capital Markets +0.99%

Debt and equity trading fueling economic growth

IBKR · ARES · MSPRE
European Banks +0.67%

Banks operating primarily in Europe

HSBC · SAN · BBVA
United Kingdom +0.36%

Stable developed market with finance and pharmaceuticals

EWU · RIO · GSK
International Banks +0.29%

Banks operating across multiple countries

HSBC · RY · SAN

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-06-2026neutral

Transcript signals

Bull points

  • The first quarter results demonstrate the benefits of the structural improvements that we have been making in the last two years.
  • We grew the top line by 6% to 8.2 billion pounds, supported by NII growth and strong activity across the investment bank.
  • Consistent capital generation and a 14.1% CET1 ratio support our plan to return at least £15 billion to shareholders by 2028, including today's £500 million buyback announcement.

Bear points

  • I am disappointed to recognize a £228 million single-name charge in the first quarter. This was in our securitized products business and relates to a well-publicized sophisticated fraud.
  • In view of increased macroeconomic and business uncertainties, we are reducing our exposure to more highly leveraged, non-investment-grade corporates, which we believe could be vulnerable to a weakening economy.
  • profit before tax up 3%
Read full transcript analysis ›